Ladouceur; Gaetan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ladouceur; Gaetan.The latest application filed is for "substituted pyrazole compounds".

Company Profile

1.13.15

Ladouceur; Gaetan - Guilford CT
Ladouceur; Gaetan - Rockville MD US
Ladouceur; Gaetan - Raleigh NC
Ladouceur; Gaetan - Branford CT
Ladouceur, Gaetan - Branrford CT
Ladouceur, Gaetan - Hamden CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diaryl ureas for diseases mediated by PDGFR Grant 8,796,250 - Wilhelm , et al. August 5, 2	2014-08-05
Tetrahydropyridothienopyrimidine compounds and methods of use thereof Grant 8,501,755 - Zhang , et al. August 6, 2	2013-08-06
Substituted pyrazolyl urea derivatives useful in the treatment of cancer Grant 8,207,166 - Lee , et al. June 26, 2	2012-06-26
Substituted Pyrazole Compounds App 20110318393 - Ladouceur; Gaetan ; et al.	2011-12-29
Urea Compounds Useful In The Treatment Of Cancer App 20110195110 - Smith; Roger ; et al.	2011-08-11
Substituted Pyrazolyl Urea Derivatives Useful In The Treatment Of Cancer App 20110136809 - LEE; Wendy ; et al.	2011-06-09
Substituted pyrazolyl urea derivatives useful in the treatment of cancer Grant 7,838,524 - Lee , et al. November 23, 2	2010-11-23
Benzofuran derivatives useful for treating hyper-proliferative disorders Grant 7,659,412 - Zhang , et al. February 9, 2	2010-02-09
Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders Grant 7,585,888 - Zhang , et al. September 8, 2	2009-09-08
Furopyridine And Furopyrimidine Derivatives For The Treatment Of Hyper-proliferative Disorders App 20090143412 - Zhang; Chengzhi ; et al.	2009-06-04
Benzofuran And Benzothiophene Derivatives Useful In The Treatment Of Hyper-proliferative Disorders App 20090054514 - ZHANG; Chengzhi ; et al.	2009-02-26
Substituted Pyrazole Compounds App 20090029992 - AGOSTON; GREGORY E. ; et al.	2009-01-29
Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders Grant 7,429,584 - Zhang , et al. September 30, 2	2008-09-30
Substituted Pyrazolyl Urea Derivatives Useful in the Treatment of Cancer App 20080214545 - Lee; Wendy ; et al.	2008-09-04
Fused tricyclic heterocycles useful for treating hyper-proliferative disorders Grant 7,384,947 - Zhang , et al. June 10, 2	2008-06-10
Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders Grant 7,351,735 - Zhang , et al. April 1, 2	2008-04-01
Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis App 20070105851 - Cook; James ; et al.	2007-05-10
Diaryl ureas with kinase inhibiting activity App 20070020704 - Wilhelm; Scott ; et al.	2007-01-25
Fused tricyclic heterocycles useful for treating hyper-proliferative disorders App 20060287387 - Zhang; Chengzhi ; et al.	2006-12-21
Fused tricyclic heterocycles useful for treating hyper-proliferative disorders Grant 7,144,885 - Zhang , et al. December 5, 2	2006-12-05
Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders App 20060040960 - Zhang; Chengzhi ; et al.	2006-02-23
Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders App 20050165042 - Zhang, Chengzhi ; et al.	2005-07-28
Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders App 20050139814 - Zhang, Chengzhi ; et al.	2005-06-30
Diaryl ureas for diseases mediated by PDGFR App 20050059703 - Wilhelm, Scott ; et al.	2005-03-17
3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors App 20040267017 - Bierer, Donald E ; et al.	2004-12-30
Piperazine-substituted pyrroloanthracenes Grant 5,409,932 - Schwenner , et al. April 25, 1	1995-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.